{
    "title": "Individual feed for https://www.marketbeat.com/feed/",
    "link": "https://www.marketbeat.com/feed/",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-08-11T06:53:23.456068",
    "items": [
        {
            "title": "3 Dividend Stocks Raising Payouts—and Backing It Up With Results",
            "link": "https://www.marketbeat.com/stock-ideas/3-dividend-stocks-raising-payoutsand-backing-it-up-with-results/",
            "description": "Three companies are increasing their dividend payouts to show strength in their underlying financials, as well as potential upside in the coming month...",
            "pubDate": "2025-08-10T09:43:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png"
        },
        {
            "title": "3 Stocks With Monopoly Power—and Minimal Competition",
            "link": "https://www.marketbeat.com/stock-ideas/3-stocks-with-monopoly-powerand-minimal-competition/",
            "description": "Three near-monopoly companies have been left behind as hotter names have taken over investor attention recently, creating upside opportunities.",
            "pubDate": "2025-08-10T08:47:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?",
            "link": "https://www.marketbeat.com/originals/rocket-lab-reports-q2-results-is-the-bull-thesis-still-intact/",
            "description": "Despite missing EPS estimates, RKLB delivered strong Q2 2025 revenue results, with sales up 36% YoY, driven by launch activity and satellite growth.",
            "pubDate": "2025-08-09T10:02:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly",
            "link": "https://www.marketbeat.com/stock-ideas/trump-glp-1-pilot-program-could-boost-novo-nordisk-and-eli-lilly/",
            "description": "Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif...",
            "pubDate": "2025-08-09T10:00:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Now Is a Great Time to Buy Cheniere Energy: New High Expected",
            "link": "https://www.marketbeat.com/originals/now-is-a-great-time-to-buy-cheniere-energy-new-high-expected/",
            "description": "Cheniere Energy is well-positioned to benefit from rising LNG demand globally, delivering capital to shareholders the entire time.",
            "pubDate": "2025-08-09T09:01:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        }
    ]
}